by NMS | Sep 28, 2023 | 2023, News
On September 21st were presented at the EU Commission Joint Research Center in Ispra the results of the method “Inhibition of thyroid hormones glucuronidation using liquid chromatography/mass spectrometry” developed by Accelera within the frame of the EU-NETVAL...
by NMS | Sep 25, 2023 | 2023, Events, News
September 25th, 2023 Nerviano Medical Sciences S.r.l., a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud to announce its participation to the World ADC 2023 summit that will...
by NMS | Sep 21, 2023 | 2023, Events, News
Nerviano Medical Sciences (NMS), una Biotech focalizzata sulla ricerca e sviluppo di farmaci Oncologici innovativi, partecipa alla Settimana Europea delle Biotecnologie (European Biotech Week – EBW), giunta quest’anno alla sua XI edizione. La EBW è una settimana...
by NMS | Sep 20, 2023 | 2023, News
Nerviano, September 20, 2023 – Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A. and a clinical stage biotech, discovering and developing innovative therapies for the treatment of cancer, today announces the publication of preclinical data on...
by NMS | Sep 19, 2023 | 2023, News
September 19th, 2023 2023 | News NERVIANO, Italy—September 19th, 2023—SIMIS Srl (SIMIS), a NMS Group company, is pleased to announce the appointment of Laurent Contaut as the new Chief Executive Officer (CEO) of the organization, effective immediately. The appointment...
by NMS | Sep 11, 2023 | 2023, News
Nerviano Italy, 11 September 2023 – Nerviano Medical Sciences Srl (NMS Srl), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that Alberto Ocana PhD, has joined the Global...
Welcome and Check out our new motion picture!
Recent Comments